MYOV stock: buy or sell?
May 14th, 2020
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases.
Should I buy MYOV stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading plan that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Myovant Sciences stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Myovant Sciences stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't detect any rating for MYOV stock for the last month.
MYOV stock analysis
After sliding a chilling -10.82% yesterday, Myovant Sciences closed today at $12.04 and stayed steady a tiny 0.25%.
After sliding a chilling -10.82% yesterday, Myovant Sciences closed today at $12.04 and stayed stable a tiny 0.25%. For the last 35 days when MYOV stock price broke up the SMA200d line, it gained $3.29 (37.60%). Since SMA100d and SMA200d crossed up on February, MYOV price slid a -4.37%.
After boosting an extraordinary 11.93% in a week last week, Myovant Sciences closed this week at $12.04 and plummed a shocking -4.90%.
Since price and SMA40w lines crossed up by mid April, MYOV climbed $2.44 (25.42%). Since SMA20w and SMA40w crossed up late January, MYOV price slid a -13.26%.
MYOV stock price history
MYOV IPO was on October 27th, 2016 at $15.00 per share1. Since then, MYOV stock declined a -19.70%, with a yearly average of -6.60%.
1: Adjusted price after possible price splits or reverse-splits.
MYOV stock historical price chart
MYOV stock reached 52-week highs on December at $19.58, and all-time highs 2018-09-24 with a price of 27.45.
MYOV stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' MYOV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price target for Myovant Sciences stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, Myovant Sciences presented its financial report, posting a slightly fine growth for the Earnings per Share (EPS). Analyst expected $-0.99 per share, but Myovant Sciences posted $-1.04.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to , last anual turnover report draw of to million USD. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .
Quarterly financial resultsReported quarter earnings marked $-70.63 M with a profit margin of . Profit margin stayed steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Myovant Sciences sales marked a tight move and stayed steady a nan%. Looking back to recent quarterly results, Myovant Sciences posted 7 positive quarters in a row.
Myovant Sciences ownershipWhen you are planning to invest in shares of a stock, it's always worth to check its ownership structure.
Myovant Sciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 59.91% of all shares.
In case of Myovant Sciences stock, 37.60% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for MYOV stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Myovant Sciences:
|Market cap||$1.1 B|
|Total shares||89.7 M|
|Float shares||35.0 M|
|- Institutional holdings (%)||37.6%|
|- Insider holdings (%)||59.9%|
|Shares in short selling||0.0%|
|Thursday, May 14th, 2020|
|Day range||$11.55 - $12.34|
|Average true range||$0.86|
|50d mov avg||$9.88|
|100d mov avg||$11.50|
|200d mov avg||$9.91|
Myovant Sciences performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Myovant Sciences, the benchmark is made against .